A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 35/14 (2006.01) A61L 2/16 (2006.01) A61P 31/04 (2006.01) A61M 1/36 (2006.01)
Patent
CA 2615637
A method for preventing bacterial biofilm formation in a blood product, the method comprising modifying a blood product with a polymer selected from the group consisting of polyethylene glycol (PEG), PEG derivatives and mixtures thereof. Preventing bacterial biofilm formation in this way increases the planktonic to adherent ratio of any contaminating bacteria, and thereby facilitates detection of bacterial contamination.
Maurer Elisabeth
Ramirez-Arcos Sandra M.
Scott Mark Alastair
Canadian Blood Services
Norton Rose Canada S.e.n.c.r.l.,s.r.l./llp
LandOfFree
Prevention of biofilm formation using pegylated blood products does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prevention of biofilm formation using pegylated blood products, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of biofilm formation using pegylated blood products will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1358267